Jeffrey Gruenglas

Mr. Gruenglas is Senior Director, Government Affairs and Health Policy, for ADMA Biologics. In this capacity, he plays a central role in developing and implementing coordinated advocacy strategies and engagements with governmental and policy entities around issues that impact the IVIG therapeutic area and biopharmaceuticals in general.